Emerging immune checkpoint inhibitors for the treatment of head and neck cancers.

Expert Opinion on Emerging Drugs
Sarah E GreenRanee Mehra

Abstract

Introduction: The benefits of immune checkpoint inhibitors (ICIs) in recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) have been demonstrated through multiple studies to improve overall survival (OS) with decreased side effects when compared to the standard of care (SOC) treatment regimens in place for decades, leading to the approval of two ICIs, nivolumab and pembrolizumab. There has been a subsequent influx in the development of novel immunotherapy agents for the treatment of HNSCC. Areas covered: Data for anti-programmed cell death protein 1 (PD-1)/programmed death ligand 1 (PD-L1) and anti-cytotoxic T-lymphocyte associated protein 4 (CTLA-4) antibodies in treatment of R/M HNSCC will be reviewed. Emerging immune checkpoint inhibitors as well as combined therapies in HNSCC will be discussed. The role of predictive biomarkers, HPV-status, PD-L1 expression, and challenges related to treating patients with ICIs will be summarized. Expert opinion: A shift toward ICIs as SOC for the treatment of R/M HNSCC will continue as emerging immune checkpoints and combination therapies are evaluated. Response rates are variable in this patient population underlying the importance of identifying predictive bioma...Continue Reading

References

Dec 22, 1999·The Journal of Immunology : Official Journal of the American Association of Immunologists·L J ApplemanV A Boussiotis
Mar 13, 2001·Annual Review of Immunology·D H RauletC W McMahon
Sep 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Yoshiko IwaiNagahiro Minato
Oct 12, 2002·BMJ : British Medical Journal·R J Sanderson, J A D Ironside
Dec 13, 2003·Cancer Gene Therapy·Adam T C CheukBarbara-ann Guinn
Mar 3, 2004·European Journal of Immunology·Simona RonchettiCarlo Riccardi
Mar 18, 2005·Annual Review of Immunology·Tania H Watts
Jan 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Minh Diem VuXian Chang Li
Feb 9, 2006·Current Opinion in Immunology·Karl S PeggsJames P Allison
May 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Pejman SorooshNaoto Ishii
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farin KamangarWilliam F Anderson
Jul 27, 2006·Nature Reviews. Immunology·Ethan M Shevach, Geoffrey L Stephens
Sep 12, 2008·The New England Journal of Medicine·Jan B VermorkenRicardo Hitt
Nov 19, 2010·Current Topics in Microbiology and Immunology·Monica V Goldberg, Charles G Drake
Jan 11, 2011·Cellular & Molecular Immunology·Dass S Vinay, Byoung S Kwon
Jan 15, 2011·Clinical & Developmental Immunology·A E AlbersA M Kaufmann
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Jan 1, 2010·Clinical & Developmental Immunology·Anaëlle DuraySven Saussez
Dec 25, 2012·Oncoimmunology·Carsten RietherAdrian F Ochsenbein
Mar 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mario Sznol, Lieping Chen
Mar 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert H Vonderheide, Martin J Glennie
Jul 19, 2013·The Journal of Clinical Investigation·Anusha KalbasiNeha Vapiwala
Apr 10, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Janis M TaubeRobert A Anders
May 14, 2014·Oral Oncology·Dan P Zandberg, Scott E Strome
Jan 27, 2015·Annual Review of Immunology·Seng-Ryong WooThomas F Gajewski
Mar 13, 2015·Frontiers in Oncology·Stefanie N LinchWilliam L Redmond
Apr 4, 2015·Science·Ton N Schumacher, Robert D Schreiber
Apr 15, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Melissa L JohnsonGregory J Riely
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Sep 10, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert L Ferris
Sep 29, 2015·The New England Journal of Medicine·Hossein BorghaeiJulie R Brahmer
Nov 13, 2015·American Journal of Clinical Oncology·Elizabeth I Buchbinder, Anupam Desai
Nov 13, 2015·JAMA Oncology·Aaron R Hansen, Lillian L Siu
Dec 10, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sandrine AspeslaghAurélien Marabelle
Jan 1, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Frederick J Kohlhapp, Howard L Kaufman
Mar 6, 2016·Mayo Clinic Proceedings·Shanthi Marur, Arlene A Forastiere

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Related Papers

Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
V DoganC-J Busch
© 2021 Meta ULC. All rights reserved